Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


natlawreview.com > press-releases > enhertur-demonstrated-median-progression-free-survival-143-months-first-line

Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial

13+ hour, 42+ min ago   (848+ words) Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). In the primary endpoint analysis, Enhertu monotherapy significantly reduced…...


indianpharmapost.com > startup > c-camp-national-bio-entrepreneurship-competition-2026-recognises-15-startups-and-four-student-teams-21825

C-CAMP National Bio Entrepreneurship competition 2026 recognises 15 startups and four student teams

14+ hour, 34+ min ago   (509+ words) The winners were announced at the finale held in Bengaluru, in the presence of Kiran Mazumdar-Shaw, Executive Chairperson, Biocon Limited Fifteen startups and four student teams have emerged as winners of the ninth edition of the C-CAMP National Bio Entrepreneurship…...


crisprmedicinenews.com > news > cmn-moderates-panel-discussion-at-csgct-2026-in-vivo-crispr-medicine-from-scientific-promise-to-p

News: CMN Moderates Panel Discussion at CSGCT 2026??? In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale

12+ hour, 9+ min ago   (337+ words) CMN Moderates Panel Discussion at CSGCT 2026 – In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale CRISPR Medicine News CMN Moderates Panel Discussion at CSGCT 2026 – In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale CMN founder Jens-Ole…...


natlawreview.com > press-releases > enhertur-fam-trastuzumab-deruxtecan-nxki-demonstrated-median-progression

ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial

13+ hour, 42+ min ago   (1000+ words) AstraZeneca and Daiichi Sankyo’s ENHERTU is the first HER2-directed therapy to delay disease progression over standard of care in a Phase III trial in this setting Results were presented today during the Presidential Symposium at the IASLC 2026 World Conference on…...


newsbytes.ph > 09/14/2026 > uk-microscopy-firm-expands-ph-operations-with-cavite-office

UK microscopy firm expands PH operations with Cavite office

12+ hour, 54+ min ago   (230+ words) The company also launched a localized website as part of the expansion, which is focused on manufacturing clusters in Calabarzon and Cebu. Vision Engineering supplies optical and digital systems used for quality control and non-contact measurement. Its products include the…...


asianbusinessreview.com > commentary > eastward-shift-in-biotech-world-why-india-and-china-could-lead-next-wave

The eastward shift in the biotech world: Why India and China could lead the next wave

16+ hour, 19+ min ago   (747+ words) China’s advantage is scale across discovery and development, and India in cost-efficiency and innovation footprint. For decades, the global biotechnology map was largely defined by a handful of established centres in the United States, and Europe. Boston, the Bay Area,…...


biospace.com > press-releases > tagrisso-osimertinib-demonstrated-unprecedented-eight-year-landmark-survival-in-early-stage-egfr-mutated-lung-cancer-in-adaura-phase-iii-trial

TAGRISSO?? (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial

12+ hour, 57+ min ago   (605+ words) Longest survival data ever reported in a global Phase III trial in this setting New data reinforce TAGRISSO as the standard of care and backbone therapy in EGFRm lung cancer across stages These results were presented today during the Presidential…...


pharmadispatch.com > news > melbourne-biotechs-psychedelic-infusion-keeps-binge-eating-disorder-at-bay-three-months-after-tr

Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends

14+ hour, 6+ min ago   (131+ words) PharmaDispatch Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends Six patients who had lived with binge eating disorder for as long as two decades sat down for two infusions of an experimental psychedelic drug....


knowyourmeme.com > photos > 3319547

Companies that test on animals... wait | /r/memes

23+ hour, 58+ min ago   (52+ words) Zach Sweat • 16 days ago Zach Sweat • 19 days ago Phillip Hamilton • 8 months ago Owen Carry • 4 years ago Uploaded by Reddit Moments Sep 13, 2026 at 01:20PM EDT Resolution: (1111px x 846px) File size: 76.5 KB 31 views (31 from today) Uploaded Sep 13, 2026 at 01:20PM EDT...